129 related articles for article (PubMed ID: 1700224)
1. Inhibition of low Km cyclic GMP phosphodiesterases and potentiation of guanylate cyclase activators by cicletanine.
Silver PJ; Buchholz A; Dundore RL; Harris AL; Pagani ED
J Cardiovasc Pharmacol; 1990 Sep; 16(3):501-5. PubMed ID: 1700224
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.
Silver PJ; O'Connor B; Cumiskey WR; Van Aller G; Hamel LT; Bentley RG; Pagani ED
J Pharmacol Exp Ther; 1991 Apr; 257(1):382-91. PubMed ID: 1850474
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
[TBL] [Abstract][Full Text] [Related]
4. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
5. Reduction by (-)-cicletanine of the vascular reactivity to angiotensin II in rats.
Alvarez-Guerra M; Alda O; Morin E; Allard M; Garay RP
J Cardiovasc Pharmacol; 1996 Oct; 28(4):564-70. PubMed ID: 8891883
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
Delpy E; le Monnier de Gouville AC
Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
[TBL] [Abstract][Full Text] [Related]
9. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
10. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
Delpy E; Coste H; Gouville AC
Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
[TBL] [Abstract][Full Text] [Related]
11. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
13. Vasorelaxant mechanism of the new vasodilator, FK409.
Isono T; Koibuchi Y; Sato N; Furuichi A; Nishii M; Yamamoto T; Mori J; Kohsaka M; Ohtsuka M
Eur J Pharmacol; 1993 Aug; 246(3):205-12. PubMed ID: 7901040
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
15. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
[TBL] [Abstract][Full Text] [Related]
16. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
Souness JE; Brazdil R; Diocee BK; Jordan R
Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
[TBL] [Abstract][Full Text] [Related]
17. Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta.
Schini V; Schoeffter P; Miller RC
Br J Pharmacol; 1989 Jul; 97(3):853-65. PubMed ID: 2547488
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.
Chilvers ER; Giembycz MA; Challiss RA; Barnes BJ; Nahorski SR
Br J Pharmacol; 1991 May; 103(1):1119-25. PubMed ID: 1652339
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
Ijioma SC; Challiss RA; Boyle JP
Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
Martin W; White DG; Henderson AH
Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
